Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$34,252
in 1 filing

Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis Mark Steven −$34K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-09-17 Capone Mark Christopher President & C.E.O. Returned to the company −11,025 $46.35 $511K 321,150
2018-09-17 Sanders Walter Lloyd President Myriad Oncology Returned to the company −844 $46.35 $39K 24,117
2018-09-17 LANCHBURY JERRY S Chief Scientific Officer Returned to the company −6,515 $46.35 $302K 132,294
2018-09-17 MARSH RICHARD M E.V.P., General Counsel Returned to the company −6,314 $46.35 $293K 110,260
2018-07-11 Capone Mark Christopher President & C.E.O. Exercise or conversion +77,654 $30.12 $2.3M 409,829
2018-07-11 Capone Mark Christopher President & C.E.O. Sale −77,654 $41.00 $3.2M 332,175
2018-07-11 Capone Mark Christopher President & C.E.O. Exercise or conversion +2,346 $30.12 $71K 334,521
2018-07-11 Capone Mark Christopher President & C.E.O. Sale −2,346 $41.00 $96K 332,175
2018-07-11 Capone Mark Christopher President & C.E.O. Exercise or conversion · Incentive Stock Option (right to buy) −2,346 0
2018-07-11 Capone Mark Christopher President & C.E.O. Exercise or conversion · Non-Qualified Stock Option (right to buy) −77,654 0
2018-07-11 HENDERSON JOHN T Director Exercise or conversion +10,000 $24.39 $244K 59,743
2018-07-11 HENDERSON JOHN T Director Sale −10,000 $44.00 $440K 49,743
2018-07-11 HENDERSON JOHN T Director Exercise or conversion +10,000 $24.39 $244K 59,743
2018-07-11 HENDERSON JOHN T Director Sale −10,000 $42.01 $420K 49,743
2018-07-11 HENDERSON JOHN T Director Exercise or conversion +10,000 $24.39 $244K 59,743
2018-07-11 HENDERSON JOHN T Director Sale −10,000 $40.17 $402K 49,743
2018-07-11 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 20,000
2018-07-11 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 10,000
2018-07-11 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 0
2018-07-11 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +46,139 $30.34 $1.4M 184,948

Page 40 of 60 · 1,194 trades